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The term pathogenetics has been coined to encompass the var-
ious and different mechanisms involved in pathogenesis of ge-
netic diseases. It comprises the study of mutations, the study of
mutagens, the study of the different pathogenetic mechanisms
that result from disordered gene functions secondary to the
change of gene structure, the study of the pathophysiological
alterations in cellular functions secondary to the ensuing dis-
turbances of the metabolic-regulatory networks that mediate
and control these functions and, ﬁnally, the study of pathogen-
esis of genetic diseases.
2. Pathogenesis of genetic diseases
Genetic diseases are caused by mutations, or structural
changes of the genetic material at any of its organizational lev-
els. Mutations cause disturbances and alterations of the struc-
ture and/or function of the genetic material, leading ultimately
to one or more of the following consequences:
1. Deletion, or loss, of part of a gene, one or many genes, part
of a chromosome, one or more chromosomes, one or more
of mitochondrial genes, or even a whole genome.
2. Duplication/rearrangement of the genetic material.
3. Deﬁcient/defective transcription of mRNA.
4. Deﬁcient/defective post-transcriptional modiﬁcations of
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6. Deﬁcient/defective post-translational modiﬁcations of
proteins.
7. Deﬁcient/defective synthesis of genetic regulatory factors.
These include transcription nucleoproteins, transcription
factors, microRNA, etc [1].Irrespective of the site, type, nature or magnitude of themutational event(s) that drastically affect the genetic material,
the resultant alterations in gene function(s) trigger many dis-
turbances in one or more of the cellular metabolic regulatory
networks mediated by the deﬁcient/defective gene products,
thus leading to a wide and varied spectrum of pathophysiolog-
ical changes in cellular functions leading, ultimately, to devel-
opment of genetic diseases.
The speciﬁc pathognomonic phenotype that characterizes
each genetic disease is primarily determined by the spectrum
of pathophysiological changes in affected subjects. These, in
turn, are determined by the spectrum of the mutation-induced
damage to the genetic material in affected patients.ier B.V. All rights reserved.
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Mutation entails any uncoded or unprogramed permanent
structural alteration of the genetic material at any of its orga-
nizational levels. These levels comprise a spectrum beginning
with single nucleotide or a part of the nucleotide (base, sugar,
phosphate), DNA, RNA, genes, chromosomes, mitochondrial
DNA (mtDNA) up to the whole genome.
The effects of mutations differ widely according to many
factors. These factors include the nature and target of the
mutagen, the timing and magnitude of the resulting damage,
and the balance between synergistic effects and anti-mutation
mechanisms of the genetic material.
Mutations may occur without an identiﬁable cause and are
termed spontaneous mutations, or they may occur secondary
to exposure to a known cause, and are referred to as induced
mutations. Factors that can induce mutations in the genetic
material are called mutagens [2].
4. Classiﬁcation of mutagens
A. According to their nature, mutagens are classiﬁed into
three main categories:
1. Chemical mutagens: these compounds are innumer-
able in the environment and include, for example,
organic compounds, asbestos, insecticides, herbi-
cides, heavy metals, etc.
2. Physical mutagens: these include particulate radia-
tions like X ray, alpha particles, UV waves at
2800 A˚ wavelength, solar radiation, thermal and
mechanical agitation of nucleic acids.
3. Biological mutagens: these include living microor-
ganisms like some viruses (cytomegalovirus, rubella
virus and herpes virus) and toxoplasma gondii.
B. According to their pathogenetic effects, mutagens are
classiﬁed into four main categories:
1. Non-speciﬁc mutagens.
2. Carcinogens are mutagens that induce malignant
transformations in affected cells.
3. Clastogens are mutagenic agents that can induce
chromosome breaks in affected cells.
4. Teratogens are mutagens that cause congenital mal-
formations in exposed fetuses.Mutagens: types, eﬀects and examples
Mutagens Eﬀects Examples
Carcinogens Carcinogenesis
and tumor
formation
Chemical: Aﬂatoxins
Biological: Retroviruses
Physical: X-ray irradiation
Clastogens Chromosome
breaks,
deletions,
rearrangements
Chemical: Bleomycin
Biological: HIV virus
Physical: UV waves
Teratogens Congenital
malformations
Chemical: Valproate
Biological: Toxoplasma gondii
Physical: X-ray irradiation
Non-speciﬁc
mutagens
Non-speciﬁc
damage to the
genetic material
Chemical: Innumerable types
Physical: X-ray irradiation
Biological: Toxoplasma, VirusesClassiﬁcation of mutation
1. Induced versus spontaneous mutation
2. Nuclear versus mitochondrial mutation
3. Somatic versus germinal mutation
4. Static versus dynamic mutation
5. Pathological versus non-pathological mutation
6. Point, small, gross and genomic mutation
7. Base, sugar, phosphate group mutation.
8. Persistent versus reversible mutation.
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Induced mutations are structural alterations of the genetic
material that occur due to exposure to the effects of any of
the known mutagens. Spontaneous mutations, on the other
hand, happen, probably, on regular basis because of the intrin-
sic nature of the genome. For instance, insertional mutations
caused by spontaneous or programed movement of the trans-
posons represent a major source of spontaneous mutations.
Tautomerism of bases of the DNA also account for a consid-
erable fraction of spontaneous mutations of the genetic
material.
4.2. Nuclear and mitochondrial mutations
Nuclear mutations are mutations that affect nuclear genes car-
ried on the chromosomes. Single gene disorders result from nu-
clear mutations that affect one or both genes of these
disorders. Mitochondrial mutations affect genes of the mito-
chondria. Due to the presence of multiple copies, tens to thou-
sands, of each mitochondrial gene inside each mitochondrion,
pathogenesis of mitochondrial disorders requires the affection
of a large fraction, nearly 80%, of the copies of the speciﬁc dis-
ease gene responsible for the mitochondrial disorder by the
mutation.
5. Somatic and germinal mutations
Somatic mutations are mutations that affect the genome of so-
matic cells. The consequences of these mutations span a wide
spectrum of pathological effects that include immediate or
gradual cell death, progressive failure of cell functions, induc-
tion of apoptosis and malignant transformation. Conversely,
germinal mutations that affect germinal cells are characterized
by being heritable mutations. If the affected germ cell partici-
pates in fertilization and formation of the zygote, the mutation
will be inherited leading to affection of the offspring.6. Static and dynamic mutations
Static mutations are mutations that are transmitted as they are
from an affected parent to an offspring. The mutation in the
offspring is identical to that of the parent. Dynamic mutations,
on the contrary, are mutagenic changes that increase in magni-
tude upon transmission from a carrier parent to his offspring.
Triplet repeat expansion mutations that account for a large
number of genetic diseases like fragile X mental retardation,
Friedreich ataxia, Huntington’s disease and many others, rep-
resent an obvious example of dynamic mutations of the human
genome.
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Pathological mutations are mutations that cause genetic disor-
ders secondary to their damaging effects on structural, regula-
tory or master genes involved in the synthesis of proteins,
transcription of non-coding RNA subtypes and the regulation
of various vital cellular functions. Many mutations, however,
do not result in pathological consequences to affected cells
due to many factors, e.g. they might affect the non-genic parts
of DNA, same-sense point mutations and mutations that are
corrected by DNA and/or RNA repair systems. Miss-sense
mutations of structural genes that affect amino acids in non-
critical domains of the protein do not result in pathophysiolog-
ical alterations or functional deterioration, rather they might
result in non-pathological changes of other aspects of the pro-
tein, e.g., its molecular weight or its electrophoretic mobility [3].8. Point, small, gross and genomic mutations
Mutations are arbitrarily classiﬁed according to the magnitude
of the mutational damage into point, small, gross and genomic
mutations. Point mutations refer to mutation of one single
base of the gene irrespective of the size of the gene. Small
mutations involve larger mutations of many bases, one or
more exons or introns and one or more genes. Gross mutations
comprise chromosomal abnormalities where tens, or even hun-
dreds, of genes are affected by deletion, inversion or transloca-
tion. Genomic mutations represent the extreme end of the
spectrum of mutations where the whole genome undergoes
mutational changes. Triploidy and tetraploidy represent rare
examples of these genomic mutations. Also, aberrant develop-
ment of vesicular moles and dermoid cysts represent clear
examples of genomic mutations due to disordered imprinting
of the whole haploid genome of the germinal cells following
fertilization.9. Base, sugar, phosphate mutations
Mutations, in general, refer to changes of the bases of the nu-
cleic acids (A,G,C,T,U) and represent the commonest types of
mutations of the genetic material. However, several kinds of
mutations can affect the sugar portion of the nucleotide. Some
physical and chemical mutagens can add an oxygen to the
deoxyribose of DNA or remove an oxygen from the ribose
of RNA or a whole deoxyribonucleotide might be substituted
by a ribonucleotide. Such mutants with a ribonucleotide, in-
stead of a deoxyribonucleotide, are usually silent but under
abnormal conditions they might be attacked by ribonucleases
leading to DNA breaks. Methylation of ribose of a coding
nucleotide in mRNA may, also, lead to silencing or, even, to
total suppression of translation.
Mutations that affect the phosphorus atom of the nucleo-
tide can cause widespread detrimental effects on the integrity
of the DNA strand. Irradiation turns ordinary phosphorus
to radioactive phosphorus which, upon release of an electron,
changes to non-radioactive sulfur and suffers a recoil in diam-
eter leading to loss of its connection to the adjacent sugar. This
results in multiple recoil breaks in the sugar-phosphate back-
bone of the DNA with ultimate breakage mutations of the nu-
cleic acid.10. Persistent and reversible mutations
Persistent mutations are mutations that cannot be corrected by
the repair systems of the genome, get ﬁxed in the affected por-
tion of the genetic material and act as permanent structural
alterations that can be transmitted, or inherited, from a carrier
parent to an offspring. Reversible mutations, on the other
hand, represent transitory programed changes of the genetic
material that mediate speciﬁc transient regulatory functions,
e.g., base methylation for suppression of gene function when
there is no need for more of the gene product. Reversible
mutations also include mutations corrected by repair systems
and reversible breakage and reformation of hydrogen bonds
between bases of the DNA following thermal agitation of
the molecule [4].Conﬂicts of interest
No conﬂicts of interest to declare.Appendix A. Part II: MCQ
K.1. MCQs – Medical genetics
Select only the best one answer for each question:
1. Genetic counseling includes all of the following
EXCEPT:
A. Recommendation of speciﬁc reproductive options
B. Assessment of the occurrence or recurrence risk
C. Discussion of the impact of the disease on the
patient and family
D. Discussion of available therapies
E. Discussion of available genetic testing.
2. A true statement regarding Noonan Syndrome is:
A. Is a chromosomal syndrome
B. Is an autosomal recessive disorder
C. Is called ‘‘male Turner’’ and only affect males
D. Aortic stenosis is the most common cardiac
abnormality
E. Mutation in PTPN11 gene is associated with 50%
of the cases.
3. A liver transplant may be effective in treating all of the
following disorders EXCEPT:
A. Severe familial hypercholesterolemia
B. a-1 antitrypsin deﬁciency
C. Ornithine transcarbamylase (OTC) deﬁciency
D. Tyrosinemia type I
E. b-thalassemia major.
4. Prenatal diagnosis of congenital hypothyroidism is pos-
sible through determining:
A. Maternal levels of free T4 and TSH
B. Amniotic ﬂuid level of Reverse T3
C. Maternal levels of free T4 and Thyroglobulin
D. Fetal biparietal diameter
E. Frequency of fetal movement.
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through genetic engineering involving:
A. Bacteria containing recombinant plasmids
B. Yeast carrying foreign genes
C. Transgenic plants
D. Mammals producing substances in their milk
E. All of the above.
6. The term imprinting indicates:
A. Loss of heterozygosity
B. Suppression of one parental allele by the other allele
C. Downregulation of heterochromatin
D. Differential suppression of genes based on parental
origin
E. Variable timely expression of clinical features.
7. Which of the following is NOT a component in treat-
ment of Homocystinuria:
A. Vitamin B6
B. Folic Acid
C. 3-Methyl Glycine
D. Vitamin B12
E. Antioxidants.
8. Peutz-Jeghers syndrome (PJS) is characterized by all of
the following EXCEPT:
A. Gastrointestinal polyposis and mucocutaneous
pigmentation
B. Innate cellular immunodeﬁciency
C. Affected individuals are at increased risk of
malignancies
D. Can be diagnosed both prenatally and postnatally
by molecular testing
E. It is inherited in an autosomal dominant manner.
9. Chromosome breakage syndromes include None of the
following EXCEPT:
A. Nijmegen syndrome
B. Hashimoto’s Thyroiditis
C. Shwachman syndrome
D. Rett syndrome
E. Smith-Lemli-Opitz syndrome.
10. Chediak-Higashi syndrome is characterized by the fol-
lowing features EXCEPT:
A. Partial albinism
B. Nystagmus
C. Megakaryocyte inclusion granules
D. Recurrent infections
E. Increased susceptibility to develop malignant
lymphoma.
11. Core signs/symptoms of Autism include the following
EXCEPT:
A. Disturbed Social interactions and relationships
B. Defective verbal and nonverbal communication
C. Enhanced feelings of fear of dangerous situations.
D. Limited interests in activities or play
E. Abnormal reactions to sensory stimuli.12. New treatments of Phenylketonuria include the follow-
ing EXCEPT:A. Neutral amino acids supplementation
B. Omega 3 & Omega 6 supplementation
C. Aspartame consumption instead of sugar
D. Biopterin cofactor
E. High-dose tyrosine supplementation.
13. Workup investigations for short stature include:
A. Measuring serum level of insulin-like growth fac-
tor-1 (IGF-I)
B. Measuring serum levels of growth hormone (GH)
C. High resolution banding karyotype
D. Measuring serum level of insulin-like growth fac-
tor-binding protein-3 (IGFBP-3)
E. All of the above.
14. The following statements about Megaloblastic anemia
are correct EXCEPT:
A. It is due to impaired DNA synthesis
B. Its most common causes are cobalamin (vitamin B-
12) and folate deﬁciencies
C. Repeated packed RBCs’ transfusion therapy repre-
sents the mainstay of therapy
D. Reducing homocysteine levels improve vascular
outcome in affected patients
E. Zollinger-Ellison syndrome can cause megaloblas-
tosis and anemia.
15. The following statements about Pseudogenes are wrong
EXCEPT:
A. They represent evolutionary remnants of junk
DNA
B. They are found exclusively in heterochromatin
regions of chromosomes
C. They can take over the functions of imprinted genes
D. Some pseudogenes play a role in gene regulation
and expression
E. They can be identiﬁed due to their rich content of A
& T nucleotides.Model answers.
1 A 6 D 11 C
2 E 7 E 12 C
3 E 8 B 13 E
4 B 9 A 14 C
5 E 10 C 15 DReferences
[1] Re´dei GP. Encyclopedia of genetics, genomics, proteomics and
informatics. third ed. New York, USA: Springer; 2008.
[2] Dale Jeremy W, Park Simon F. Molecular genetics of bacteria.
fourth ed. John Wiley & Sons Ltd; 2004.
[3] Watson James D et al.. Molecular biology of the gene. ﬁfth ed.
Menlo Park, Calif., USA: Benjamin; 2004.
[4] Pasternak JJ. An introduction to human molecular genetics.
second ed. Hoboken, NJ, USA: Wiley-Liss, John Wiley & Sons
Inc; 2005.
[5] Benjamin A. Pierce. genetics. A conceptual approach. second ed.
Gordonsville, VA, USA: W.H. Freeman & company; 2005.
